Table 5.

Health utility values for studies involving patients with any type of chronic wound derived from the EuroQol 5 Dimension 5

Study	EQ-5D Details	Wounds	Population	Health Utility
Tennvall et al. (2000)104	EQ-5D-3L, UK tariff	DFUs	Swedish adults	0.44
Morgan et al. (2006)105	EQ-5D-3L, NR	DFUsa	UK adults	0.29–0.51b
Michaels et al. (2009)106	EQ-5D-3L, UK tariff	VLUs	UK adults	0.65
Soares et al. (2009)107	EQ-5D-3L, TTO	VLUs	UK adults	0.50
Chuang et al. (2011)108	EQ-5D-3L, UK tariff	VLUs	UK adults	0.52
Padula et al. (2011)109	EQ-5D-3L, NR	PIs	American adults	0.6
Javanbakht et al. (2012)110	EQ-5D-3L, UK VAS tariff	DFUsa	Iranian adults	0.62
Siersma et al. (2017, 2013)111,112	EQ-5D-3L, NR	DFUs	European adults	0.65
Sobol et al. (2013)113	EQ-5D-3L, Polish tariff	DFUs	Polish adults	0.62
Li et al. (2017)114	EQ-5D-3L, Canadian tariff	DFUs	Canadian adults	0.59
Sothornwit et al. (2018)115	EQ-5D-5L, TTO	DFUs	Thai adults	0.70
Selva-Sevilla et al. (2020)116	EQ-5D-3L, Spanish tariff	Chronic wounds	Spanish adults	0.55
Arab-Zozani et al. (2022)65	EQ-5D-5L, cTTO	DFUs	Iranian adults	0.55

^a Only small percentages had DFUs.

^b Depending on type of diabetic comorbidities present.

cTTO, composite time trade-off; EQ-5D, EuroQol 5 Dimension 5; EQ-5D-3L, European Quality of Life 5 Dimensions 3 Level Version; EQ-5D-5L, European Quality of Life 5 Dimensions 5 Level Version; NR, not reported; TTO, time trade-off; VAS, Visual Analog Scale.